Structural anomalies reveajed by neuroimaging studies in the brains of patients with neurofibromatosis type 1 and large deletions

Genetics in Medicine

Volumn 1, Issue 4, 1999, Pages 136-140

  Korf, Bruce R ^a   Schneider, Gretchen ^a   Poussaint, Tina Young ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETICS; HUMAN; INTELLIGENCE TEST; MALE; MENTAL DEFICIENCY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DELETION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL RETARDATION; NEUROFIBROMATOSIS 1; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033123544     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/00125817-199905000-00004     Document Type: Article

References (22)

1. Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: The cognitive phenotype. J Pediatr 1994;124:S1-S8.
2. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Suva M. Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology 1994;44:878-883.
3. Eldridge R, Denckla MB, Bien E, Myers S, Kaiser-Kupfer MI, Pikus A, Schlesinger SL, Parry DM, Dambrosia JM, Zasloff MA, Mulvihill JJ. Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child 1989;143:833-837.
4. Legius E, Descheemaeker MJ, Spaepen A, Casaer P, Fryns JP. Neurofibromatosis type I in childhood: A study of the neuropsychological profile in 45 children. Genet Couns 1994;5:51-60.
5. North KN, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla MB. Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force. Neurology 1997;48:1121-1127.
6. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111:1355-1381.
7. Carey JC, Laub JM, Hall BD. Penetrance and variability in neurofibromatosis: A genetic study of 60 families. Birth Defects: Original Article Series 1979;15, No. 56:271-281.
8. Rosman NP, Pearce J. The brain in multiple neurofibromatosis (von Recklinghausen's disease): A suggested neuropathological basis for the associated mental defect. Brain 1967;90:829-838.
9. Daston MM, Ratner N. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn 1993;195:216-226.
10. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N. The protein product of the neurofibromatosis type I gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 1992;8:415-428.
11. Es SV, North KN, McHugh K, Suva MD. MRI findings in children with neurofibromatosis type 1: A prospective study. Pediatr Radiol 1996;26:478-487.
12. Itoh T, Magnaldi S, White RM, Denckla MB, Hofman K, Naidu S, Bryan RN. Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities. Am J Neuroradiol 1994;15:1513-1519.
13. Terada H, Barkovich AJ, Edwards MS, Ciricillo SM. Evolution of high-intensity basal ganglia lesions on T1-weighted MR in neurofibromatosis type I. Am J Neuroradiol 1996;17:755-760.
14. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI 1 abnormalities in children with neurofibromatosis. Neurology 1989;39:373-378.
15. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. Am J Roentgenol 1988;151:381-388.
16. Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ. Relationship between T2-weighted hyperinten-sities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102.
17. Ferner RE, Chaudhuri R, Bingham I, Cox T, Hughes RA. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56:492-495.
18. Kayes LM, Riccardi VM, Burke W, Bennett RL, Stephens K. Sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet 1992;29:686-687.
19. Leppig KA, Kaplan P, Viskochil D, Weaver M, Ortenberg J, Stephens K. Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial phenotype and early onset of cutaneous neurofibromata. Am I Med Genet 1997;73:197-204.
20. Leppig KA, Viskochil D, Neil S, Rubenstein A, Johnson VP, Zhu XL, Brothman AR, Stephens K. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization. Cytogenet Cell Genet 1996;72:95-98.
21. Wu BL, Austin MA, Schneider GH, Boles RG, Korf BR. Deletion of the entire NF1 gene detected by FISH: Four deletion patients associated with severe manifestations. Am J Med Genet 1995;59:528-535.
22. Wu BL, Schneider GH, Korf BR. Deletion of the entire NF1 gene causing distinct manifestations in a family. Am J Med Genet 1997;69:98-101.